Insider Transactions in Q1 2026 at Rapport Therapeutics, Inc. (RAPP)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 15
2026
|
David Bredt Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,500
-1.05%
|
$229,500
$27.12 P/Share
|